Please CLICK HERE to visit the Alabama NewsCenter website to see this article in its entirety and any other images or videos that go with the article.
By James Paton and Stephanie Baker
Bloomberg
A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, which is a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen.
The vaccine increased levels of protective neutralizing antibodies and immune T-cells that target the virus, according to the study organizers. The results were published Monday in The Lancet medical journal.
AstraZeneca shares rose as much as 10% in London but gave up much of the gain to trade 0.6% higher as researchers cautioned that the results are preliminary. A positive outcome had been widely expected after reports last week lifted the stock, with the vaccine already in more advanced trials.
